Article
Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
Cardiovascular research - 1 Feb 2003
Havndrup Ole, Bundgaard Henning, Andersen Paal Skytt, Allan Larsen Lars, Vuust Jens, Kjeldsen Keld, Christiansen Michael
Abstract excerpt
OBJECTIVE: Familial hypertrophic cardiomyopathy (FHC) is caused by mutations in genes encoding cardiac sarcomere proteins. Although available, genetic analyses are generally not used clinically. In the present study, we evaluated the outcome of clinical vs. genetic screening of family members with specific focus on mutations in the cardiac beta-myosin heavy chain (MYH7) gene. METHODS: A consecutive cohort of 68...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
